ALBANY, N.Y., Nov. 20, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to participate in a Q&A session at the 25th Annual Piper Jaffray Healthcare Conference at The New York Palace Hotel in Manhattan. AngioDynamics' Q&A session will be at 11 a.m. Eastern Time, Tuesday, December 3, 2013. Joseph DeVivo, President and Chief Executive Officer, will review the Company's business strategy and recent corporate developments.
A live webcast and subsequent archived replay of AngioDynamics' Q&A session may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact: AngioDynamics, Inc. Mark Frost, CFO (800) 772-6446 x1981 mfrost@AngioDynamics.com Investor Relations Contacts: EVC Group, Inc. Michael Polyviou/Robert Jones (212) 850-6020; (646) 201-5447 firstname.lastname@example.org; email@example.com Media Contact: EVC Group, Inc. John Carter (212) 850-6021 firstname.lastname@example.orgSource:AngioDynamics